Nivolumab
2023-503317-29-00
Phase 3 small_molecule active
Quick answer
Nivolumab for Metastatic Kidney Cancer is a Phase 3 program (small_molecule) at Rein Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rein Therapeutics
- Indication
- Metastatic Kidney Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active